Revenio Group Oyj

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FI0009010912
EUR
21.80
0.25 (1.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 591 Million ()

stock-summary
P/E

36.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

16.97%

stock-summary
Price to Book

5.42

Revenue and Profits:
Net Sales:
26 Million
(Quarterly Results - Jun 2025)
Net Profit:
3 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.64%
0%
-6.64%
6 Months
-23.1%
0%
-23.1%
1 Year
-21.07%
0%
-21.07%
2 Years
-7.86%
0%
-7.86%
3 Years
-48.39%
0%
-48.39%
4 Years
-59.21%
0%
-59.21%
5 Years
-46.7%
0%
-46.7%

Revenio Group Oyj for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
14.13%
EBIT Growth (5y)
7.34%
EBIT to Interest (avg)
22.40
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
0.84
Tax Ratio
24.71%
Dividend Payout Ratio
57.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
30.11%
ROE (avg)
21.01%
Valuation key factors
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
6.25
EV to EBIT
23.95
EV to EBITDA
20.54
EV to Capital Employed
6.42
EV to Sales
6.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
26.81%
ROE (Latest)
17.34%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 4.33% vs 13.90% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -24.39% vs 28.12% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "26.50",
          "val2": "25.40",
          "chgp": "4.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.20",
          "val2": "7.00",
          "chgp": "2.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.10",
          "val2": "4.10",
          "chgp": "-24.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "230.20%",
          "val2": "204.70%",
          "chgp": "2.55%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 7.14% vs -0.41% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -3.14% vs -12.39% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "103.50",
          "val2": "96.60",
          "chgp": "7.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.90",
          "val2": "30.10",
          "chgp": "-0.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.80",
          "chgp": "-12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "18.50",
          "val2": "19.10",
          "chgp": "-3.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "238.60%",
          "val2": "270.50%",
          "chgp": "-3.19%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
26.50
25.40
4.33%
Operating Profit (PBDIT) excl Other Income
7.20
7.00
2.86%
Interest
1.70
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
3.10
4.10
-24.39%
Operating Profit Margin (Excl OI)
230.20%
204.70%
2.55%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 4.33% vs 13.90% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -24.39% vs 28.12% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
103.50
96.60
7.14%
Operating Profit (PBDIT) excl Other Income
29.90
30.10
-0.66%
Interest
0.70
0.80
-12.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
18.50
19.10
-3.14%
Operating Profit Margin (Excl OI)
238.60%
270.50%
-3.19%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 7.14% vs -0.41% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -3.14% vs -12.39% in Dec 2023

stock-summaryCompany CV
About Revenio Group Oyj stock-summary
stock-summary
Revenio Group Oyj
Pharmaceuticals & Biotechnology
Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
Company Coordinates stock-summary
Company Details
Ayritie 22 , VANTAA None : 01510
stock-summary
Tel: 358 9 87751150
stock-summary
Registrar Details